logo
  • Home
  • Applications
    • Indications
  • Business
  • Technology
  • Investors
    • Investors Overview
    • Results and Presentations
    • Share Price Information
    • Regulatory News
    • Board & Governance
    • Key Corporate Documents
    • AIM Rule 26
    • Email Alerts
    • Investor Contacts
  • News
  • About Us
    • History
    • Board of Directors
    • Management Team
    • Scientific Advisory Panel
    • Values
    • Careers
  • Contact Us
  • Service

Month: October 2015

Frost & Sullivan awards OBD the Best Innovative Technology 2015, for its Biomarker Discovery Platform in Monaco.

Frost & Sullivan award press release

 

by Catia Gaspar

The Stratification Medicine Grant Project initiates collection of first blood samples from ALS patients at the Nuffield Department of Clinical Neuroscience (OBD - Chronos Therapeutics - University of Oxford).

by Catia Gaspar

Dr. Aroul Ramadass gives a talk on EpiSwitch™ technology translation at the Medical Device Conference "See Manufactures in Action: Rapid Transformation", Berlin, Germany.

by Catia Gaspar

A pilot study of chromosomal aberrations and epigenetic changes in peripheral blood samples to identify patients with melanoma.

Melanoma Research, 25(5):406-11, 2015

by oxfordbiodynamics

Terms of Use 
Site Map

Privacy Policy
Cookies Policy

Regulated and Licensed by Human Tissue Authority
License No. 12571

© 2002-2018 Oxford Biodynamics Plc

Privacy Preference Center

Privacy Preferences

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with this.OkRead more